EDGAR Filing Documents for 0001193125-17-003007

Form POS AM - Post-Effective amendments for registration statement:

SEC Accession No. 0001193125-17-003007

Filing Date

2017-01-05

Accepted

2017-01-05 16:32:56

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	POS AM	d296367dposam.htm	POS AM	147757
2	EX-23.1	d296367dex231.htm	EX-23.1	1723
	Complete submission text file	0001193125-17-003007.txt		150668

Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421

Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904

Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)